Month: February 2011

  • By Donald Zuhn — Last week, the U.S. Patent and Trademark Office provided additional details regarding its proposed "Three Track" patent examination initiative.  An outline of the Office's Three Track program, or Enhanced Examination Timing Control Initiative, was originally provided in a Federal Register notice (75 Fed. Reg. 31763) published last June (see "USPTO Publishes…

  • By Sherri Oslick — About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases. Somaxon Pharmaceuticals Inc. et al. v. Par Pharmaceutical Inc. et al.1:11-cv-00107; filed February 2, 2011 in the District Court of Delaware • Plaintiffs:  Somaxon Pharmaceuticals Inc.; Procom One Inc.• Defendants:  Par Pharmaceutical Inc.; Par Pharmaceutical…

  • February 8, 2011 – Corporate Intellectual Property Law Conference (Law Bulletin Publishing Company) – Chicago, IL February 9, 2011 – Patent Claim Indefiniteness: Enzo v. Applera (Intellectual Property Owners Association) – 2:00 PM (ET) February 9-10, 2011 – BioPharma IP Innovations Summit (Strategic Solutions Network) – Miami, FL February 16-17, 2011 – Life Sciences Collaborative…

  • The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Patent Claim Indefiniteness: Enzo v. Applera" on Wednesday, February 9, 2011 beginning at 2:00 PM (ET).  The IPO webinar will address the question:  just how definite do the claims of a patent need to be?  The webinar will look at the Federal Circuit's…

  • The Law Bulletin Publishing Company will be holding its annual Corporate Intellectual Property Law Conference on February 8, 2011 in Chicago, IL.  The conference will address the following topics: General Sessions • The State of the USPTO — "Strategic Perspectives on Intellectual Property: Inside and Out (of the USPTO)" — Sharon Barner, former Deputy Director…

  • By Kevin E. Noonan — The Senate Judiciary Committee met today and passed S. 23, the Patent Reform Act of 2011, sending it to the Senate floor for consideration.  The vote was 15 ayes, no nays, and on abstention (by Senator John Cornyn, R-TX).  But prior to the vote, there were several (but fewer than…

  • By Donald Zuhn — Last week, Senator Herb Kohl (D-WI) (at right) introduced the Preserve Access to Affordable Generics Act (S. 27) in the Senate.  The bill, which is co-sponsored by Senators Sherrod Brown (D-OH), Susan Collins (R-ME), Richard Durbin (D-IL), Al Franken (D-MN), Chuck Grassley (R-IA), Amy Klobuchar (D-MN), and Bernard Sanders (I-VT), is…

  • By James DeGiulio — Jury Awards Abbott $16M in Tarka Patent Suit Against Glenmark Abbott Laboratories has been awarded $16 million in its suit against Glenmark Pharmaceuticals over a generic version of the blood pressure drug, Tarka, after a federal jury found Glenmark liable for infringement.  In October 2007, Glenmark notified Abbott and Sanofi that…